These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 10961361

  • 1. Evaluation of haemostatic and fibrinolytic markers in patients with Cushing's syndrome and in patients with adrenal incidentaloma.
    Ambrosi B, Sartorio A, Pizzocaro A, Passini E, Bottasso B, Federici A.
    Exp Clin Endocrinol Diabetes; 2000; 108(4):294-8. PubMed ID: 10961361
    [Abstract] [Full Text] [Related]

  • 2. Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly.
    Sartorio A, Cattaneo M, Bucciarelli P, Bottasso B, Porretti S, Epaminonda P, Faglia G, Arosio M.
    Exp Clin Endocrinol Diabetes; 2000; 108(7):486-92. PubMed ID: 11083070
    [Abstract] [Full Text] [Related]

  • 3. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C.
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [Abstract] [Full Text] [Related]

  • 4. Markers of vascular function in hypertension due to Cushing's syndrome.
    Zacharieva S, Atanassova I, Nachev E, Orbetzova M, Kirilov G, Kalinov K, Shigarminova R.
    Horm Metab Res; 2005 Jan; 37(1):36-9. PubMed ID: 15702437
    [Abstract] [Full Text] [Related]

  • 5. [Retrospective hormonal analysis of incidentally discovered and operated adrenal tumors for subclinical Cushing's syndrome].
    Przybylik-Mazurek E, Buziak-Bereza M, Fedorowicz A, Kuźniarz-Rymarz S, Stochmal E, Hubalewska-Dydejczyk A.
    Przegl Lek; 2010 Jan; 67(12):1270-5. PubMed ID: 21591352
    [Abstract] [Full Text] [Related]

  • 6. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A, Ruusuvaara L.
    Thromb Haemost; 1988 Dec 22; 60(3):361-4. PubMed ID: 3149043
    [Abstract] [Full Text] [Related]

  • 7. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A, Murray RD, Teasdale GM, Shalet SM.
    Clin Endocrinol (Oxf); 2004 Apr 22; 60(4):476-83. PubMed ID: 15049963
    [Abstract] [Full Text] [Related]

  • 8. Von Willebrand factor and fibrinolytic parameters during the desmopressin test in patients with Cushing's disease.
    Pecori Giraldi F, Ambrogio AG, Fatti LM, Rubini V, Cozzi G, Scacchi M, Federici AB, Cavagnini F.
    Br J Clin Pharmacol; 2011 Jan 22; 71(1):132-6. PubMed ID: 21143510
    [Abstract] [Full Text] [Related]

  • 9. Blood coagulation and fibrinolysis in patients with Cushing's syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels.
    Erem C, Nuhoglu I, Yilmaz M, Kocak M, Demirel A, Ucuncu O, Onder Ersoz H.
    J Endocrinol Invest; 2009 Feb 22; 32(2):169-74. PubMed ID: 19411818
    [Abstract] [Full Text] [Related]

  • 10. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].
    Nowakowska A.
    Ann Acad Med Stetin; 2005 Feb 22; 51(1):95-105. PubMed ID: 16496609
    [Abstract] [Full Text] [Related]

  • 11. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR.
    Dan Med Bull; 2002 Feb 22; 49(1):43-60. PubMed ID: 11894723
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of markers of bone and collagen turnover in patients with active and preclinical Cushing's syndrome and in patients with adrenal incidentaloma.
    Sartorio A, Conti A, Ferrero S, Giambona S, Re T, Passini E, Ambrosi B.
    Eur J Endocrinol; 1998 Feb 22; 138(2):146-52. PubMed ID: 9506857
    [Abstract] [Full Text] [Related]

  • 13. Androgen secretion in ectopic ACTH syndrome and in Cushing's disease: modifications before and after surgery.
    Barbetta L, Dall'Asta C, Re T, Colombo P, Travaglini P, Ambrosi B.
    Horm Metab Res; 2001 Oct 22; 33(10):596-601. PubMed ID: 11607879
    [Abstract] [Full Text] [Related]

  • 14. [Studies of the basal secretion and the response to TRH (thyrotropin-relapsing factor) of TSH (thyrotropin) and prolactin in Cushing's syndrome and Nelson's syndrome (author's transl)].
    Luton JP, Molinie P, Strauch G, Guilhaume B, Bricaire H.
    Sem Hop; 2001 Oct 22; 57(17-18):841-9. PubMed ID: 6262921
    [Abstract] [Full Text] [Related]

  • 15. Hypercoagulability in Cushing's syndrome: the role of specific haemostatic and fibrinolytic markers.
    Kastelan D, Dusek T, Kraljevic I, Polasek O, Giljevic Z, Solak M, Salek SZ, Jelcic J, Aganovic I, Korsic M.
    Endocrine; 2009 Aug 22; 36(1):70-4. PubMed ID: 19381886
    [Abstract] [Full Text] [Related]

  • 16. The fibrinolytic potential in patients with Cushing's disease: a clue to their hypercoagulable state.
    Patrassi GM, Sartori MT, Viero ML, Scarano L, Boscaro M, Girolami A.
    Blood Coagul Fibrinolysis; 1992 Dec 22; 3(6):789-93. PubMed ID: 1489900
    [Abstract] [Full Text] [Related]

  • 17. Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing's syndrome: results from a prospective study before and after surgery.
    Manetti L, Bogazzi F, Giovannetti C, Raffaelli V, Genovesi M, Pellegrini G, Ruocco L, Iannelli A, Martino E.
    Eur J Endocrinol; 2010 Nov 22; 163(5):783-91. PubMed ID: 20696792
    [Abstract] [Full Text] [Related]

  • 18. Endothelial haemostatic markers in members of families with familial combined hyperlipidemia.
    Karásek D, Vaverková H, Halenka M, Slavík L, Novotný D.
    Thromb Res; 2009 Nov 22; 123(3):466-75. PubMed ID: 18417194
    [Abstract] [Full Text] [Related]

  • 19. Circadian pattern of serum androgens in women with Cushing's syndrome.
    Kreze A, Mikulecky M, Putz Z, Moravcik M.
    Acta Med Hung; 2009 Nov 22; 49(3-4):171-8. PubMed ID: 1345454
    [Abstract] [Full Text] [Related]

  • 20. Personality characteristics and quality of life in patients treated for Cushing's syndrome.
    Sonino N, Bonnini S, Fallo F, Boscaro M, Fava GA.
    Clin Endocrinol (Oxf); 2006 Mar 22; 64(3):314-8. PubMed ID: 16487442
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.